EXPLORE!

DiabetesIndia 2022: What is the role of gliptins in diabetes management?

  850 Views

Dr Purvi Chawla, Mumbai    02 July 2022

Gliptins or DPP-IV inhibitors are highly safe and efficacious oral, inexpensive antidiabetic agents.They are one of the most preferred second-line agents when there is a compelling need to reduce hypoglycemia or reduce the cost of therapy.

Not only is the risk of hypoglycemia very low to negligent with gliptins but they are also weighted neutral.Most gliptins are CV safe too.

They make an ideal choice of drug for especially the elderly and may be used in mild-to-moderate renal and hepatic disease too with dose modifications.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.